TEK and neoplasm: The anti‐tumor effects of ABTAA (an Ang2 oligomerizing antibody that activates Tie2) were recently evaluated in several mouse tumor models (Park et al,2017); its anti‐metastatic potential to lymph nodes and lung were also shown but only in the presence of unresected primary tumors (Table 4).